Cosmetic ingredients

22/11/2026 9 min read

Hydroxypropyl cyclodextrin in cosmetics: complexation and safety

Hydroxypropyl cyclodextrin is not a skin care active. It is an inclusion complexing agent that helps dissolve, protect and retain other ingredients in the formula. Understanding the equilibrium behind inclusion complexes helps brand owners choose the concentration, the preservative system and an appropriate level of product claims.

Hydroxypropyl cyclodextrin in cosmetics: complexation and safety
Illustrative image: a fine ivory-white powder — hydroxypropyl cyclodextrin is a hydrophilic derivative of cyclodextrin, used as an inclusion complexing agent in cosmetics

Hydroxypropyl cyclodextrin (INCI: Hydroxypropyl Cyclodextrin) is an etherified derivative of cyclodextrin, a cyclic oligosaccharide with a hydrophilic outer surface and a less hydrophilic central cavity. In cosmetics, it is a formulation aid, not a skin care active: it forms inclusion complexes with poorly soluble molecules to increase their apparent solubility, protects certain actives, retains fragrance and masks odors.

1. What is hydroxypropyl cyclodextrin?

According to the final report (October 2015) of the CIR (Cosmetic Ingredient Review) Expert Panel, Hydroxypropyl Cyclodextrin is a propylene glycol ether of Cyclodextrin. The same report defines Cyclodextrin as a cyclic polysaccharide made up of 6 to 8 glucopyranose units, and lists two CAS numbers for this INCI name: 128446-33-3 and 128446-35-5. In terms of nomenclature, therefore, the INCI name does not correspond to just one ring size.

The form most often found in the literature is hydroxypropyl-β-cyclodextrin (HP-β-CD, a ring of 7 glucose units); the European Pharmacopoeia has a dedicated monograph for it under the name Hydroxypropylbetadex (EMA, 2017). According to the summary table by Mitrofan-Bandol et al. (2026), HP-β-CD carries on average about 0.60–0.65 hydroxypropyl groups per glucose unit, has an average molecular weight of about 1,400 Da and a water solubility of 600 mg/mL or more (parent β-cyclodextrin: 18.5 mg/mL).

HP-β-CD is a mixture of molecules that differ in their number of substituents and has no fixed molecular formula; when comparing raw materials, check the certificate of analysis (COA) for the ring type (α, β or γ), the degree of substitution and the impurity specifications.

2. Mechanism: “host–guest” inclusion complexes

  • Inclusion complex formation: cyclodextrins form water-soluble complexes with many lipophilic, poorly soluble molecules; for example, HP-β-CD increases the solubility of methylparaben, and the stability constant of the 1:1 complex is 2150 M−1 (Tanaka et al., 1995). Molecules inside the cavity are always in dynamic equilibrium with free molecules (Loftsson and Masson, 2001).
  • Little skin penetration of its own: because of their large size and hydrophilicity, only negligible amounts of cyclodextrins and their complexes pass through intact skin (Loftsson and Masson, 2001). In hairless mice, after 24-hour occlusive application of a radiolabeled 2% HP-β-CD solution, the amount that permeated intact skin was about 0.02% of the applied amount, compared with about 24% when the stratum corneum had been stripped (Tanaka et al., 1995, as cited in the CIR report).
  • Modulating how much active reaches the skin: cyclodextrins increase the amount of active available at the skin surface, where the active leaves the cavity to enter the stratum corneum; this mechanism appears to operate only in the presence of water (Loftsson and Masson, 2001). Because this is an equilibrium, the amount of active entering the skin can increase or decrease depending on the ratio and concentration (section 3).
  • Fragrance retention, odor masking: according to the EMA review (2017), cosmetics containing HP-β-CD retain their scent longer; in medicines, cyclodextrins are used to reduce unpleasant odors and tastes.

3. Evidence: mostly on formulation, little human data

In the sources searched (PubMed, November 2026), no trial was found that evaluated this ingredient itself as an active for improving the skin. Directly relevant studies:

StudyModelConcentrationMain resultsNotes
Pany et al., 2021Parallel groups, 15 healthy people, applied to the forearm every evening, 4 weeks1% HP-β-CD in a submicron emulsion and a submicron emulsion gel; the control was a gel without HP-β-CDNo statistically significant changes in skin barrier, hydration, sebum or skin pHTolerability study, not an efficacy study; small sample size; the full text reports financial support from a company
Tanaka et al., 1995Excised hairless mouse skin and live mice2% HP-β-CD (in mice)66% reduction in the amount of methylparaben absorbed through the skin after 24 hours; HP-β-CD itself was very poorly absorbedAnimal study; authors affiliated with a cosmetics company
Yang et al., 2008Franz diffusion cells; in vivo sunscreen test (species not stated in the abstract)Avobenzone 0.12 mg/mL, HP-β-CD 0–30%Skin permeation increased as HP-β-CD rose to 20% and decreased at 30%; the 30% formulation was more photostable, with fewer sunburn cells and less edema30% is far above the levels reported for use in cosmetics

Overall assessment: limited evidence for any claim of skin benefit from hydroxypropyl cyclodextrin itself. According to the review by Mitrofan-Bandol et al. (2026), in many experiments, hydrophilic derivatives such as HP-β-CD extracted less cholesterol and disturbed the skin barrier less than methylated β-cyclodextrins.

4. Typical concentrations and product types

The 2015 CIR report compiled U.S. reported-use data (the FDA’s VCRP database in 2015 and an industry concentration survey) for Hydroxypropyl Cyclodextrin:

Use categoryNumber of reported usesConcentration (%)
Total530.00001–2
Leave-on products520.00001–2
Rinse-off products10.02–0.1
Eye area130.02–1.3
Underarm deodorants10.34–2 (pump spray: up to 0.34)

The studies reviewed used 1% (Pany et al., 2021) and 2% (Tanaka et al., 1995); levels of 20–30% appear only in experiments (Yang et al., 2008). The amount needed depends on the substance to be complexed and is determined on trial batches. No independent source reviewed states the pH stability range of the raw material; refer to the supplier’s technical data sheet (TDS).

Suitable product types: water-based serums and toners that need to dissolve poorly soluble ingredients; deodorant sprays; products that need lasting fragrance. Some extracts are supplied as blends with this ingredient, for example white willow bark; see the article on white willow bark (Salix alba) (in Vietnamese).

5. Using it in formulas: dos and don’ts

  • Preservatives: HP-β-CD can reduce the efficacy of preservatives, especially lipophilic ones such as phenolic compounds (Lehner et al., 1994); methylparaben also forms a complex with HP-β-CD (Tanaka et al., 1995). The preservative system must be challenge-tested according to ISO 11930 on the final formula; see the article on ISO 11930 preservative challenge testing (in Vietnamese).
  • Fragrance: part of the fragrance is held in the cavity; adjust the amount of fragrance on trial samples (formulation experience).
  • Competition for the cavity: fragrance, preservatives and lipophilic actives in the same formula compete to occupy the cavity (Loftsson and Masson, 2001). When changing ingredients, recheck the active content and the clarity.
  • Actives that need to enter the skin: HP-β-CD in excess of the amount needed to fully dissolve the active can keep the active on the surface and reduce penetration (Yang et al., 2008) — an advantage for UV filters (see the article on avobenzone (in Vietnamese)), but for actives that need to penetrate, several ratios must be tested.

6. Safety: who should take care

CIR (2015) placed Hydroxypropyl Cyclodextrin among the 105 polysaccharides concluded to be safe in the present practices of use and concentration in cosmetics. The report relied in part on the 0.02% penetration data mentioned above, and noted that the industry should apply good manufacturing practices (GMP) to limit impurities, including the agents used to modify polysaccharides.

EMA (2017), citing a 1997 review, states: β-cyclodextrin did not cause irritation or allergic contact dermatitis in repeated occlusive patch tests in human volunteers; studies of antigenicity, mutagenicity and local irritation showed HP-β-CD to be as safe as materials currently used in perfumes and cosmetics. At sufficiently high concentrations, the parent cyclodextrins irritate guinea pig skin (γ < α < β), depending on their ability to extract skin lipids (EMA, 2017).

Data on oral and injectable medicines (diarrhea after high oral doses; kidney toxicity in animals at high systemic exposure) belong to the pharmaceutical context and do not apply directly to topical cosmetics (EMA, 2017).

People with reactive skin should try the product on a small area of skin first. Pregnant or breastfeeding women: there are not enough data for topical products; ask a doctor.

7. Perspective for brand owners: pharmaceutical excipient vs. cosmetic ingredient, regulations

  • A pharmaceutical excipient is not the same as a cosmetic ingredient: HP-β-CD is on the FDA’s list of excipients and is present in oral and intravenous infusion medicines containing itraconazole (EMA, 2017). EMA proposes that medicines containing 20 mg cyclodextrin/kg/day or more state the amount of cyclodextrin in the package leaflet, together with a warning not to use them in children under 2 years of age unless recommended by a doctor. This threshold applies only to medicine package leaflets and is not a limit for cosmetics. A pharmacopoeia-grade raw material does not turn a product into a medicine and does not permit medicinal claims.
  • ASEAN regulations: Hydroxypropyl Cyclodextrin, cyclodextrin and the two CAS numbers above are not listed in Annexes II, III and VI (version 2026-1, June 22, 2026) or Annex VII (version 2025-2, December 12, 2025) of the ASEAN Cosmetic Directive, meaning there is no specific concentration limit; the product still requires a safety assessment and a Product Information File (PIF).
  • Blended raw materials: the label must list the INCI name of every component.
  • Claims: wording such as “helps dissolve and stabilize ingredients in the formula,” “supports fragrance longevity” and “molecular encapsulation technology” can be used when there are stability data for the formula itself. Avoid “reduces irritation” and “penetrates many times deeper” without data on the finished product, and avoid drug-like language.

Butter-C uses hydroxypropyl cyclodextrin in some water-based contract-manufactured products, such as the white willow bark toner (via the blended raw material mentioned in section 4) and the room and linen spray line, where it helps reduce perceived odors (a household product, not a cosmetic).

Frequently asked questions

Is hydroxypropyl cyclodextrin a skin care active?

No. It is a formulation aid that helps dissolve, protect or retain other ingredients.

Do cyclodextrins make actives penetrate deeper?

Penetration can increase or decrease depending on the ratio and the formula (sections 3 and 5); a claim requires data on the finished product.

Does hydroxypropyl cyclodextrin cause irritation?

CIR (2015) concluded that this ingredient is safe in the present practices of use and concentration. Human data are still limited: one small tolerability study (15 people, healthy forearm skin) with 1% HP-β-CD found no statistically significant effect on the skin barrier after 4 weeks.

Is a “pharmacopoeia-grade” raw material different from the grade used in cosmetics?

A pharmacopoeia-grade raw material is tested according to the pharmacopoeial monograph, but a product containing it is still a cosmetic; when choosing a raw material, compare COAs.

Can pregnant women use it?

There are not enough data for topical products containing this ingredient; ask a doctor before use.

References

  1. Cosmetic Ingredient Review Expert Panel. Safety Assessment of Polysaccharide Gums as Used in Cosmetics (Final Report, October 22, 2015). https://www.cir-safety.org/sites/default/files/plpogu092015final.pdf
  2. European Medicines Agency (CHMP). Cyclodextrins used as excipients. Report published in support of the ‘Questions and answers on cyclodextrins used as excipients in medicinal products for human use’ (EMA/CHMP/333892/2013), October 9, 2017. https://www.ema.europa.eu/en/documents/scientific-guideline/questions-and-answers-cyclodextrins-used-excipients-medicinal-products-human-use_en.pdf
  3. Mitrofan-Bandol DI et al. Decoding Cyclodextrins in Skin Applications: Structure, Mechanisms, and Safety in Cosmetic and Dermatologic Formulations (Part I). Int J Mol Sci. 2026. PMID 42278554
  4. Loftsson T, Masson M. Cyclodextrins in topical drug formulations: theory and practice. Int J Pharm. 2001. PMID 11489551
  5. Tanaka M et al. Effect of 2-hydroxypropyl-beta-cyclodextrin on percutaneous absorption of methyl paraben. J Pharm Pharmacol. 1995. PMID 8708982
  6. Pany A et al. Effect of hydroxypropyl-β-cyclodextrin in fluid and semi-solid submicron emulsions on physiological skin parameters during regular in vivo application. Int J Cosmet Sci. 2021. PMID 33236374
  7. Lehner SJ et al. Effect of hydroxypropyl-beta-cyclodextrin on the antimicrobial action of preservatives. J Pharm Pharmacol. 1994. PMID 8027925
  8. Yang J et al. Influence of hydroxypropyl-beta-cyclodextrin on transdermal penetration and photostability of avobenzone. Eur J Pharm Biopharm. 2008. PMID 18226883

Get started

Talk to us about the product you plan to launch

Please send us your product direction and expected quantities. Our team will get back to you during business hours.

Công ty cổ phần Dược mỹ phẩm Butter-C · Business registration no. 0108681386 (Hanoi Department of Planning and Investment, 03/04/2019)
Head office: Huu Le village, Dai Thanh commune, Hanoi · Factory: Thanh Oai Industrial Cluster, Binh Minh commune, Hanoi, Vietnam
Hotline 0967 176 511 · [email protected] · privacy policy
Product catalog →